What test results would indicate hyperthyroidism? Select all that apply.

Choice A reason: Bleeding is a high-risk complication for patients with pancytopenia because of the low platelet count. Platelets are crucial for blood clotting, and their deficiency leads to an increased risk of spontaneous bleeding and difficulty in stopping bleeding once it starts. This can result in significant blood loss and complications if not managed promptly.
Choice B reason: Infection is another high-risk complication for patients with pancytopenia due to the low white blood cell count. White blood cells are essential for fighting infections, and their deficiency makes patients more susceptible to bacterial, viral, and fungal infections. These infections can be severe and difficult to control, leading to further complications and increased morbidity.
Choice C reason: Seizures are not typically associated with pancytopenia. Seizures are more commonly linked to neurological conditions, electrolyte imbalances, or other underlying medical issues rather than low blood cell counts.
Choice D reason: Neurogenic shock is not a common complication of pancytopenia. Neurogenic shock occurs due to a disruption in the autonomic nervous system, often resulting from spinal cord injuries or severe central nervous system damage, rather than low blood cell counts.
Choice E reason: Pulmonary edema is not directly related to pancytopenia. Pulmonary edema involves fluid accumulation in the lungs, often due to heart failure, kidney disease, or other causes, rather than low blood cell counts.

Choice A reason:
Administering furosemide in this scenario would further lower the serum potassium level, as furosemide is a loop diuretic known for causing potassium loss through urine. This action could worsen the patient’s hypokalemia, leading to severe complications such as cardiac arrhythmias. Therefore, administering furosemide in the presence of hypokalemia is inappropriate and could put the patient at significant risk.
Choice B reason:
Administering both spironolactone and furosemide together without addressing the hypokalemia would not be safe. While spironolactone is a potassium-sparing diuretic, combining it with furosemide could negate its potassium-sparing effects. Furthermore, administering furosemide when hypokalemia is present could cause further electrolyte imbalance. Proper evaluation of the patient's condition and selective administration of the medications are crucial in this case.
Choice C reason:
Withholding both medications and attributing the decision to contraindications with hyperkalemia is incorrect because the reported potassium level (3.2 mEq/L) reflects hypokalemia, not hyperkalemia. Misinterpreting the lab result could delay appropriate treatment, such as correcting the potassium level or safely administering a medication that would not exacerbate the hypokalemia. Proper communication with the healthcare provider is necessary for effective patient care.
Choice D reason:
Administering spironolactone is the best action in this scenario because it is a potassium-sparing diuretic. By administering spironolactone, the risk of worsening hypokalemia is minimized. Notifying the healthcare provider about the low potassium level ensures appropriate monitoring and any necessary interventions, such as potassium supplementation. This approach is both safe and effective in managing the patient’s current condition while adhering to standard nursing practices.